Joana Lei Teixeira

Joana Lei Teixeira

Auto-generated profile, based on publicly available information

Joana Lei Teixeira

Clínica Universitária de Nefrologia, Faculdade de Medicina da Universidade de Lisboa, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2025 in Nefrología (English Edition)
Verified
Journal Article
Open access
BSBernardo Marques da Silva
Bernardo Marques da Silva
JGJoana Gameiro
Joana Gameiro
JTJoana Lei Teixeira
Joana Lei Teixeira
CCCláudia Costa
Cláudia Costa
Carolina BrancoCarolina Branco
Carolina Branco
JLJosé António Lopes
José António Lopes
Acute kidney injury (AKI) is frequent in hospitalized patients and contributes to adverse short- and long-term outcomes. We aimed to evaluate the association of AKI and long-term adverse renal events and mortality in a cohort of patients hospitalized with COVID-19. Single-center and retrospective study of hospitalized patients admitted to a Dedicated Unit for COVID-19 at Centro Hospitalar Universitário Lisboa Norte, Portugal, between March 2020 and October 2020. AKI was defined and classified according to the Kidney Disease: Improving Global Outcomes (KDIGO) classification, using SCr criteria. The analyzed outcomes were development of major adverse kidney events (MAKE), major adverse renal cardiovascular events (MARCE), and mortality over a two-year follow-up period. From the included 409 patients, AKI occurred in 60.4% (n=247). Within two years after discharge, 31.8% (n=130) of patients had an eGFR<60mL/min/1.73m2 and/or a 25% decrease on eGFR and 1.7% (n=7) of patients required RRT, 6.1% (n=25) of patients had CV events and 27.9% (n=114) of patients died. The incidence of MAKE was 60.9% (n=249), and MARCE was 62.6% (n=256). On a multivariate analysis, older age (adjusted HR 1.02 (95% CI: 1.01-1.04), p=0.008), cardiovascular disease (adjusted HR 2.22 (95% CI: 1.24-3.95), p=0.007), chronic kidney disease (adjusted HR 5.15 (95% CI: 2.22-11.93), p<0.001), and AKI (adjusted HR 1.76 (95% CI: 1.12-2.78), p=0.015) were independent predictors of MAKE. Older age (adjusted HR 1.06 (95% CI: 1.04-1.08), p<0.001) and neoplasia (adjusted HR 4.88 (95% CI: 2.37-10.04), p<0.001) were independent predictors of mortality. In this cohort of hospitalized patients with COVID-19, AKI was independently associated with the risk of long-term need for dialysis and/or renal function decline and/or mortality after hospital discharge.

23 August 2024 in Nefrología
Verified
Journal Article
Open access
BSBernardo Marques da Silva
Bernardo Marques da Silva
JGJoana Gameiro
Joana Gameiro
JTJoana Lei Teixeira
Joana Lei Teixeira
CCCláudia Costa
Cláudia Costa
Carolina BrancoCarolina Branco
Carolina Branco
JLJosé António Lopes
José António Lopes
Introduction and Objectives: Acute kidney injury (AKI) is frequent in hospitalized patients and contributes to adverse short- and long-term outcomes. We aimed to evaluate the association of AKI and long-term adverse renal events and mortality in a cohort of patients hospitalized with COVID-19. Material and Methods: Single-center and retrospective study of hospitalized patients admitted to a Dedicated Unit for COVID-19 at Centro Hospitalar Universitário Lisboa Norte, Portugal, between March 2020 and October 2020. AKI was defined and classified according to the Kidney Disease: Improving Global Outcomes (KDIGO) classification, using SCr criteria. The analyzed outcomes were development of major adverse kidney events (MAKE), major adverse renal cardiovascular events (MARCE), and mortality over a two-year follow-up period. Results: From the included 409 patients, AKI occurred in 60.4% (n=247). Within two years after discharge, 31.8% (n=130) of patients had an eGFR<60mL/min/1.73m2 and/or a 25% decrease on eGFR and 1.7% (n=7) of patients required RRT, 6.1% (n=25) of patients had CV events and 27.9% (n=114) of patients died. The incidence of MAKE was 60.9% (n=249), and MARCE was 62.6% (n=256). On a multivariate analysis, older age (adjusted HR 1.02 (95% CI: 1.01-1.04), p=0.008), cardiovascular disease (adjusted HR 2.22 (95% CI: 1.24-3.95), p=0.007), chronic kidney disease (adjusted HR 5.15 (95% CI: 2.22-11.93), p<0.001), and AKI (adjusted HR 1.76 (95% CI: 1.12-2.78), p=0.015) were independent predictors of MAKE. Older age (adjusted HR 1.06 (95% CI: 1.04-1.08), p<0.001) and neoplasia (adjusted HR 4.88 (95% CI: 2.37-10.04), p<0.001) were independent predictors of mortality. Conclusions: In this cohort of hospitalized patients with COVID-19, AKI was independently associated with the risk of long-term need for dialysis and/or renal function decline and/or mortality after hospital discharge.